World Journal of Surgery

, Volume 36, Issue 1, pp 55–60

Long-Term Outcome in Patients with Primary Hyperparathyroidism who Underwent Minimally Invasive Parathyroidectomy

  • Raghunandan Venkat
  • Guennadi Kouniavsky
  • Ralph P. Tufano
  • Eric B. Schneider
  • Alan P. B. Dackiw
  • Martha A. Zeiger
Article

Abstract

Background

Minimally invasive parathyroidectomy (MIP) has become a well-accepted treatment for selected patients with primary hyperparathyroidism (PHPT). However, few studies have evaluated long-term outcomes for this operative approach. We therefore chose to examine both the long-term symptom resolution and biochemical cure following MIP for PHPT.

Methods

A total of 460 PHPT patients who underwent a MIP between 2004 and 2009 were successfully mailed a questionnaire that assessed preoperative and postoperative Parathyroidectomy Assessment of Symptoms (PAS) scores, most recent calcium and parathyroid hormone (PTH) levels, and information about any reoperation for PHPT. Long-term evaluation of symptomatic and biochemical cure was performed.

Results

A total of 200 patients (43.5%) responded to our correspondence. The mean age of the patients was 58.7 ± 11.9 years, 74.5% were female, and 78.5% were Caucasian. The mean follow-up was 37 ± 19 months. The mean PAS scores fell by 117 ± 14 at long-term follow-up after MIP (P < 0.0001). All 13 symptoms comprising the PAS score diminished, of which ten did so significantly (P < 0.01). There was a significant drop in the mean serum calcium (preop. 11.1 mg/dl, postop. 9.6 mg/dl; P < 0.0001) and PTH (preop. 130.9 pg/ml, postop. 45.7 pg/ml; P < 0.0001) at long-term follow-up. Five patients (2.5%) developed recurrent disease (calcium > 10.5 mg/dl), and one (0.5%) underwent a reoperation for persistent disease and was subsequently cured.

Conclusions

This study demonstrates that MIP has long-term benefits in terms of excellent symptom resolution and a high biochemical cure rate (97%) in selected patients who have PHPT, preoperative localization with sestamibi scans, and assessment of intraoperative PTH level.

References

  1. 1.
    Eigelberger MS, Cheah WK, Ituarte PH et al (2004) The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: Are they too limited? Ann Surg 239:528–535PubMedCrossRefGoogle Scholar
  2. 2.
    Sitges-Serra A, Bergenfelz A (2007) Clinical update: sporadic primary hyperparathyroidism. Lancet 370:468–470PubMedCrossRefGoogle Scholar
  3. 3.
    Pelizzo MR, Pagetta C, Piotto A et al (2008) Surgical treatment of primary hyperparathyroidism: from bilateral neck exploration to minimally invasive surgery. Minerva Endocr 33:85–93Google Scholar
  4. 4.
    Bergenfelz A, Kanngiesser V, Zielke A et al (2005) Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism. Br J Surg 92:190–197PubMedCrossRefGoogle Scholar
  5. 5.
    Lavely WC, Goetze S, Friedman KP et al (2007) Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med 48:1084–1089PubMedCrossRefGoogle Scholar
  6. 6.
    Mihai R, Gleeson F, Buley ID et al (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30:697–704. doi:10.1007/s00268-005-0338-9 PubMedCrossRefGoogle Scholar
  7. 7.
    Heller KS, Blumberg SN (2009) Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy. Arch Otolaryngol Head Neck Surg 135:1103–1107PubMedCrossRefGoogle Scholar
  8. 8.
    Chen H, Pruhs Z, Starling JR et al (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138:583–587 discussion 587–590PubMedCrossRefGoogle Scholar
  9. 9.
    Bergenfelz A, Lindblom P, Tibblin S et al (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551PubMedCrossRefGoogle Scholar
  10. 10.
    Westerdahl J, Bergenfelz A (2007) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246:976–980 discussion 980–971PubMedCrossRefGoogle Scholar
  11. 11.
    Goldstein RE, Blevins L, Delbeke D et al (2000) Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg 231:732–742PubMedCrossRefGoogle Scholar
  12. 12.
    Tang T, Dolan S, Robinson B et al (2007) Does the surgical approach affect quality of life outcomes? A comparison of minimally invasive parathyroidectomy with open parathyroidectomy. Int J Surg 5:17–22PubMedCrossRefGoogle Scholar
  13. 13.
    Aspinall SR, Boase S, Malycha P (2010) Long-term symptom relief from primary hyperparathyroidism following minimally invasive parathyroidectomy. World J Surg 34:2223–2227. doi:10.1007/s00268-010-0687-x PubMedCrossRefGoogle Scholar
  14. 14.
    Pasieka JL, Parsons L, Jones J (2009) The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10 year prospective surgical outcome study. Surgery 146:1006–1013PubMedCrossRefGoogle Scholar
  15. 15.
    Sidhu S, Neill AK, Russell CFJ (2003) Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to presumed solitary adenoma. World J Surg 27:339–342. doi:10.1007/s00268-002-6695-8 PubMedCrossRefGoogle Scholar
  16. 16.
    Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513–518. doi:10.1007/s002689900428 discussion 518–519PubMedCrossRefGoogle Scholar
  17. 17.
    Greutelaers B, Kullen K, Kollias J et al (2004) Pasieka illness questionnaire: its value in primary hyperparathyroidism. ANZ J Surg 74:112–115PubMedCrossRefGoogle Scholar
  18. 18.
    Pasieka JL, Parsons LL, Demeure MJ et al (2002) Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26:942–949. doi:10.1007/s00268-002-6623-y PubMedCrossRefGoogle Scholar
  19. 19.
    Mihai R, Sadler GP (2008) Pasieka’s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg 32:807–814. doi:10.1007/s00268-008-9509-9 PubMedCrossRefGoogle Scholar
  20. 20.
    Irvin GL 3rd, Molinari AS, Figueroa C et al (1999) Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229:874–878 discussion 878–879PubMedCrossRefGoogle Scholar
  21. 21.
    Irvin GL 3rd, Deriso GT 3rd (1994) A new, practical intraoperative parathyroid hormone assay. Am J Surg 168:466–468PubMedCrossRefGoogle Scholar
  22. 22.
    Irvin GL 3rd, Dembrow VD, Prudhomme DL (1993) Clinical usefulness of an intraoperative “quick parathyroid hormone” assay. Surgery 114:1019–1022 discussion 1022–1013PubMedGoogle Scholar
  23. 23.
    Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15:688–692. doi:10.1007/BF01665301 PubMedCrossRefGoogle Scholar
  24. 24.
    Kaplan EL, Yashiro T, Salti G (1992) Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg 215:300–317PubMedCrossRefGoogle Scholar
  25. 25.
    Tibblin S, Bondeson AG, Ljungberg O (1982) Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma. Ann Surg 195:245–252PubMedCrossRefGoogle Scholar
  26. 26.
    Russell CF, Laird JD, Ferguson WR (1990) Scan-directed unilateral cervical exploration for parathyroid adenoma: A legitimate approach? World J Surg 14:406–409. doi:10.1007/BF01658540 PubMedCrossRefGoogle Scholar
  27. 27.
    Dackiw AP, Sussman JJ, Fritsche HA Jr et al (2000) Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 135:550–555 discussion 555–557PubMedCrossRefGoogle Scholar
  28. 28.
    Udelsman R, Donovan PI, Sokoll LJ (2000) One hundred consecutive minimally invasive parathyroid explorations. Ann Surg 232:331–339PubMedCrossRefGoogle Scholar
  29. 29.
    Irvin GL 3rd, Prudhomme DL, Deriso GT et al (1994) A new approach to parathyroidectomy. Ann Surg 219:574–579 discussion 579–581PubMedCrossRefGoogle Scholar
  30. 30.
    Shabtai M, Ben-Haim M, Muntz Y et al (2003) 140 consecutive cases of minimally invasive, radio-guided parathyroidectomy: lessons learned and long-term results. Surg Endosc 17:688–691PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2011

Authors and Affiliations

  • Raghunandan Venkat
    • 1
  • Guennadi Kouniavsky
    • 1
  • Ralph P. Tufano
    • 2
  • Eric B. Schneider
    • 1
  • Alan P. B. Dackiw
    • 1
  • Martha A. Zeiger
    • 1
    • 3
    • 4
  1. 1.Endocrine Surgery Section, Department of SurgeryJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of Otolaryngology and Head and Neck SurgeryJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of OncologyJohns Hopkins University School of MedicineBaltimoreUSA
  4. 4.Department of Cellular and Molecular MedicineJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations